173 related articles for article (PubMed ID: 35498027)
1. Tanshinone IIA Has a Potential Therapeutic Effect on Kawasaki Disease and Suppresses Megakaryocytes in Rabbits With Immune Vasculitis.
Chen H; Shu H; Su W; Li B; Zhang H; Li L; Lin C; Yi W; Zhan XY; Chen C; Li X; Yang Y; Zhou M; Yang M
Front Cardiovasc Med; 2022; 9():873851. PubMed ID: 35498027
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Tanshinone IIa on cytokines and platelets in immune vasculitis and its mechanism].
Li XJ; Zhou M; Li XH; Xu YH; Liu H; Yang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):188-92. PubMed ID: 19236776
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the anti-inflammatory activities of tanshinones isolated from Salvia miltiorrhiza var. alba roots in THP-1 macrophages.
Ma S; Zhang D; Lou H; Sun L; Ji J
J Ethnopharmacol; 2016 Jul; 188():193-9. PubMed ID: 27178632
[TBL] [Abstract][Full Text] [Related]
4. Proapoptotic and TRAIL-sensitizing constituents isolated from Salvia militiorrhiza (Danshen).
Chang CC; Lai JS; Tsai CS; Ma SW; Lin JY; Huang LR; Lu CH; Liao EC; Ho TF
J Biosci Bioeng; 2013 Oct; 116(4):516-23. PubMed ID: 23660075
[TBL] [Abstract][Full Text] [Related]
5. The anti-atherosclerotic effect of tanshinone IIA is associated with the inhibition of TNF-α-induced VCAM-1, ICAM-1 and CX3CL1 expression.
Chang CC; Chu CF; Wang CN; Wu HT; Bi KW; Pang JH; Huang ST
Phytomedicine; 2014 Feb; 21(3):207-16. PubMed ID: 24157079
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation.
Lee WY; Chiu LC; Yeung JH
Food Chem Toxicol; 2008 Jan; 46(1):328-38. PubMed ID: 17892911
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA suppresses lipopolysaccharide-induced neuroinflammatory responses through NF-κB/MAPKs signaling pathways in human U87 astrocytoma cells.
Jin H; Peng X; He Y; Ruganzu JB; Yang W
Brain Res Bull; 2020 Nov; 164():136-145. PubMed ID: 32860868
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells.
Yang LJ; Jeng CJ; Kung HN; Chang CC; Wang AG; Chau GY; Don MJ; Chau YP
J Biomed Sci; 2005; 12(2):347-61. PubMed ID: 15917998
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA Attenuates H₂O₂ -induced injury in human umbilical vein endothelial cells.
Chan P; Chen YC; Lin LJ; Cheng TH; Anzai K; Chen YH; Liu ZM; Lin JG; Hong HJ
Am J Chin Med; 2012; 40(6):1307-19. PubMed ID: 23227799
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt pathway in neonatal rat cardiomyocytes.
HONG HJ; LIU JC; CHENG TH; CHAN P
Acta Pharmacol Sin; 2010 Dec; 31(12):1569-75. PubMed ID: 21102479
[TBL] [Abstract][Full Text] [Related]
11. Do cytokines correlate with refractory Kawasaki disease in children?
Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
[TBL] [Abstract][Full Text] [Related]
12. Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer.
Lu Q; Zhang P; Zhang X; Chen J
Int J Mol Med; 2009 Dec; 24(6):773-80. PubMed ID: 19885617
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway.
Hong HJ; Liu JC; Chen PY; Chen JJ; Chan P; Cheng TH
Int J Cardiol; 2012 May; 157(2):174-9. PubMed ID: 21190747
[TBL] [Abstract][Full Text] [Related]
14. Anti-allergic effects of salvianolic acid A and tanshinone IIA from Salvia miltiorrhiza determined using in vivo and in vitro experiments.
Heo JY; Im DS
Int Immunopharmacol; 2019 Feb; 67():69-77. PubMed ID: 30537633
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA pretreatment attenuates ischemia/reperfusion-induced renal injury.
Xu YM; Ding GH; Huang J; Xiong Y
Exp Ther Med; 2016 Oct; 12(4):2741-2746. PubMed ID: 27698779
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis.
Liu JJ; Zhang Y; Lin DJ; Xiao RZ
Oncol Rep; 2009 Apr; 21(4):1075-81. PubMed ID: 19288011
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine.
Zhang W; Liu C; Li J; Lu Y; Li H; Zhuang J; Ren X; Wang M; Sun C
Am J Chin Med; 2022; 50(1):209-239. PubMed ID: 34983327
[TBL] [Abstract][Full Text] [Related]
18. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
19. Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease.
Inoue T; Murakami S; Matsumoto K; Matsuda A
Pediatr Rheumatol Online J; 2020 Oct; 18(1):76. PubMed ID: 33023630
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA Attenuates Chronic Pancreatitis-Induced Pain in Rats via Downregulation of HMGB1 and TRL4 Expression in the Spinal Cord.
Wang YS; Li YY; Wang LH; Kang Y; Zhang J; Liu ZQ; Wang K; Kaye AD; Chen L
Pain Physician; 2015; 18(4):E615-28. PubMed ID: 26218952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
